A detailed history of Grey Street Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Grey Street Capital, LLC holds 19,983 shares of JNJ stock, worth $3.11 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
19,983
Previous 3,132 538.03%
Holding current value
$3.11 Million
Previous $491 Million 544.02%
% of portfolio
0.43%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 09, 2024

BUY
$155.22 - $162.74 $2.62 Million - $2.74 Million
16,851 Added 538.03%
19,983 $3.16 Billion
Q4 2023

Jan 11, 2024

BUY
$145.6 - $158.88 $3,785 - $4,130
26 Added 0.84%
3,132 $491 Million
Q3 2023

Oct 10, 2023

SELL
$155.75 - $174.48 $28,502 - $31,929
-183 Reduced 5.56%
3,106 $484 Million
Q2 2023

Jul 13, 2023

BUY
$154.35 - $166.11 $42,291 - $45,514
274 Added 9.09%
3,289 $544 Million
Q1 2023

May 10, 2023

BUY
$151.05 - $180.26 $455,415 - $543,483
3,015 New
3,015 $467 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Grey Street Capital, LLC Portfolio

Follow Grey Street Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grey Street Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grey Street Capital, LLC with notifications on news.